Aqueous formulations of an anti-cd22 antibody and uses thereof
A stable pharmaceutical formulation of a therapeutically active anti-CD22 antibody, Suciraslimab (or SM03), for injection. In particular, the formulations comprising, in addition to a suitable amount of the anti-CD22 antibody. The formulations comprise additionally at least one buffering agent, such...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; heb |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Kwan-yin SIU Ming-hon YAU Shui-on LEUNG Ka-wa Benny CHEUNG |
| description | A stable pharmaceutical formulation of a therapeutically active anti-CD22 antibody, Suciraslimab (or SM03), for injection. In particular, the formulations comprising, in addition to a suitable amount of the anti-CD22 antibody. The formulations comprise additionally at least one buffering agent, such as a phosphate buffer and a nonionic surfactant. Methods for preparing such stable formulation and their uses thereof are also provided. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_IL312233A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>IL312233A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_IL312233A3</originalsourceid><addsrcrecordid>eNrjZLBzLCxNzS8tVkjLL8otzUksyczPK1bIT1NIzAOikkzd5BQjIzArKT-lEshIUSgtTi1WKMlILUrNT-NhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfGePsaGRkbGxo7GBBUAABAcLss</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Aqueous formulations of an anti-cd22 antibody and uses thereof</title><source>esp@cenet</source><creator>Kwan-yin SIU ; Ming-hon YAU ; Shui-on LEUNG ; Ka-wa Benny CHEUNG</creator><creatorcontrib>Kwan-yin SIU ; Ming-hon YAU ; Shui-on LEUNG ; Ka-wa Benny CHEUNG</creatorcontrib><description>A stable pharmaceutical formulation of a therapeutically active anti-CD22 antibody, Suciraslimab (or SM03), for injection. In particular, the formulations comprising, in addition to a suitable amount of the anti-CD22 antibody. The formulations comprise additionally at least one buffering agent, such as a phosphate buffer and a nonionic surfactant. Methods for preparing such stable formulation and their uses thereof are also provided.</description><language>eng ; heb</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240601&DB=EPODOC&CC=IL&NR=312233A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240601&DB=EPODOC&CC=IL&NR=312233A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Kwan-yin SIU</creatorcontrib><creatorcontrib>Ming-hon YAU</creatorcontrib><creatorcontrib>Shui-on LEUNG</creatorcontrib><creatorcontrib>Ka-wa Benny CHEUNG</creatorcontrib><title>Aqueous formulations of an anti-cd22 antibody and uses thereof</title><description>A stable pharmaceutical formulation of a therapeutically active anti-CD22 antibody, Suciraslimab (or SM03), for injection. In particular, the formulations comprising, in addition to a suitable amount of the anti-CD22 antibody. The formulations comprise additionally at least one buffering agent, such as a phosphate buffer and a nonionic surfactant. Methods for preparing such stable formulation and their uses thereof are also provided.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBzLCxNzS8tVkjLL8otzUksyczPK1bIT1NIzAOikkzd5BQjIzArKT-lEshIUSgtTi1WKMlILUrNT-NhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfGePsaGRkbGxo7GBBUAABAcLss</recordid><startdate>20240601</startdate><enddate>20240601</enddate><creator>Kwan-yin SIU</creator><creator>Ming-hon YAU</creator><creator>Shui-on LEUNG</creator><creator>Ka-wa Benny CHEUNG</creator><scope>EVB</scope></search><sort><creationdate>20240601</creationdate><title>Aqueous formulations of an anti-cd22 antibody and uses thereof</title><author>Kwan-yin SIU ; Ming-hon YAU ; Shui-on LEUNG ; Ka-wa Benny CHEUNG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_IL312233A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; heb</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Kwan-yin SIU</creatorcontrib><creatorcontrib>Ming-hon YAU</creatorcontrib><creatorcontrib>Shui-on LEUNG</creatorcontrib><creatorcontrib>Ka-wa Benny CHEUNG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Kwan-yin SIU</au><au>Ming-hon YAU</au><au>Shui-on LEUNG</au><au>Ka-wa Benny CHEUNG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Aqueous formulations of an anti-cd22 antibody and uses thereof</title><date>2024-06-01</date><risdate>2024</risdate><abstract>A stable pharmaceutical formulation of a therapeutically active anti-CD22 antibody, Suciraslimab (or SM03), for injection. In particular, the formulations comprising, in addition to a suitable amount of the anti-CD22 antibody. The formulations comprise additionally at least one buffering agent, such as a phosphate buffer and a nonionic surfactant. Methods for preparing such stable formulation and their uses thereof are also provided.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; heb |
| recordid | cdi_epo_espacenet_IL312233A |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Aqueous formulations of an anti-cd22 antibody and uses thereof |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T10%3A05%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Kwan-yin%20SIU&rft.date=2024-06-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EIL312233A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |